Blockchain announcements

Protect Pharmaceutical Product Integrity with the Pharmaceutical Utility Network

Share this post:

drug store

The Drug Supply Chain Security Act (DSCSA) Interoperability Pilot demonstrates how blockchain technology can be used to effectively track and trace certain prescription drugs throughout the supply chain. The visibility offered by blockchain makes it easier for pharmaceutical supply chain actors to comply with with the DSCSA (a U.S. law that goes into effect in 2024), prevent the distribution of counterfeit drugs, facilitate the drug recall process and more.

In December 2019, KPMG, Merck, Walmart and IBM completed the Drug Supply Chain Security Act (DSCSA) Interoperability Pilot as part of the U.S. Food and Drug Administration (FDA) DSCSA Pilot Project Program. The pilot’s findings demonstrate that leveraging blockchain technology can significantly reduce the time needed to trace a prescription drug — from up to 16 weeks to two seconds.

 

The current state of healthcare and the DSCSA

The healthcare industry continues to change rapidly, but its legacy issues remain and manifest in new ways. Though more information is available and accessible than ever before, counterfeiting continues to plague the industry.

These are but a subset of the issues that healthcare supply chains face in the context of rapid urbanization, aging global populations and increasing cost pressures.

The Drug Supply Chain Security Act (DSCSA), which was enacted in 2013 by the FDA and will be implemented in phases over the next decade, reflects the U.S. government’s increasing focus on these challenges and the essential need for visibility into the end-to-end pharmaceutical supply chain. The law requires supply chain stakeholders to digitally track and trace certain prescription drugs and their distribution within the U.S.

 

medical records

 

supply chain fact1supply chain fact2

 

 

 

The FDA DSCSA Interoperability Pilot

IBM and its partners completed work for the FDA Drug Supply Chain Security Act (DSCSA) Interoperability Pilot, and aim to formally launch and scale the blockchain-enabled solution to streamline and facilitate DSCSA compliance for pharmaceutical supply chain stakeholders. To comply with the DSCSA, organizations must be able to digitally verify a drug product and its journey through the end-to-end supply chain. The pilot application uses blockchain technology to digitally store pharmaceutical product profiles and track and trace products at the serialized unit level from the point of manufacture to the point of dispense.

In addition to supply chain visibility, the pilot leverages blockchain to strengthen the protection of patients and patient safety. The application allows users the ability to quickly and effectively identify, investigate, and communicate about a relevant suspect or illegitimate drug product. This eliminates data siloes between supply chain actors and has strong potential to improve and expedite the drug recall process.

user benefits

 

Learn more about the FDA DSCSA Interoperability Pilot:

  • gov: DSCSA Pilot Project Program
  • IBM News Room: IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
  • TechCrunch: IBM, KPMG, Merck, Walmart team up for drug supply chain blockchain pilot
  • Forbes: Merck and Walmart Will Track Prescription Drugs On IBM Blockchain In FDA Pilot
  • Reuters: IBM, Walmart, Merck in blockchain collaboration with FDA

 

Learn why IBM is the top-ranked blockchain for business services provider

Managing Editor

More Blockchain announcements stories

Modernizing seaport logistics with a secure blockchain solution

Have you ever thought about the complexity behind operations at a maritime port? The port ecosystem is enormous and involves a huge number of different stakeholders and entities. Each port’s daily logistics include retailers, freight forwarders, carriers, consignees, port authority, container terminals, shippers, shipping agents and more. Unfortunately, every one of these operators usually has […]

Continue reading

Automating EDI to the max: no partner left behind

At an IBM event few years ago, I watched a customer present on the great benefit he was experiencing from his Document Conversion Services (fax and email to EDI) solution. I was coming from a global, standards-driven, high-automation point of view and was surprised that he was so effusive about a solution that sounded to […]

Continue reading

Crypto and blockchain acceleration in uncertain times

There are moments that change the world, that create seismic shifts in what feels like an instant. The ongoing cycles of COVID pandemic and the fallout of the Russian war in Ukraine have changed the world. These shifts are felt daily in the world of trade, where we’re seeing new widespread adoption of digital solutions […]

Continue reading